Circulating cytokines and angiogenic factors (CAFs) in patients with advanced non-clear cell renal cell carcinoma treated with sunitinib: Results from a phase II clinical trial

被引：0
|
作者：
Bilen, Mehmet Asim [1 ]
Zurita, Amado J. [1 ]
Ilias-Khan, Nasreen A. [1 ]
Chen, Hsiang-Chun [1 ]
Wang, Xuemei [1 ]
Hodges, Sherie [1 ]
Lim, Zita D. [1 ]
Jonasch, Eric [1 ]
Khakoo, Aarif Yusuf [1 ]
Tannir, Nizar M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.483
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II efficacy trial of pazopanib in non-clear cell metastatic renal cell carcinoma (PINCR trial).
    Costello, Brian Addis
    Thai Huu Ho
    Tan, Winston
    Leibovich, Bradley C.
    Castle, Erik P.
    Parker, Alexander S.
    Dronca, Roxana Stefania
    Qin, Rui
    Kohll, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] A phase II study of lenvatinib plus everolimus in patients with advanced non-clear cell renal cell carcinoma (nccRCC)
    Hutson, Thomas E.
    Michaelson, M. Dror
    Kuzel, Timothy M.
    Agarwal, Neeraj
    Molina, Ana M.
    Hsieh, James J.
    Vaishampayan, Ulka N.
    Xie, Sharon
    Bapat, Urmi
    Jain, Rohit K.
    Fishman, Mayer N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study
    Paglino, Chiara
    Imarisio, Ilaria
    Ganini, Carlo
    Morbini, Patrizia
    Vercelli, Alessandro
    Bregant, Cristina
    Porta, Camillo
    FUTURE ONCOLOGY, 2012, 8 (12) : 1605 - 1612
  • [24] Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy
    Urman, Danielle
    Deshler, Leah
    Weise, Nicole
    Shabaik, Ahmed
    Derweesh, Ithaar
    Bagrodia, Aditya
    Rose, Brent
    Herchenhorn, Daniel
    McKay, Rana R.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : 660 - 668.e1
  • [25] Phase II trial of RAD001 in renal cell carcinoma patients with non-clear cell histology.
    Koh, Youngil
    Kim, Ji Yeon
    Lim, Ho Yeong
    Ahn, Jin-Hee
    Lee, Jae-Lyun
    Rha, Sun Young
    Kim, YuJung
    Kim, Tae Min
    Lee, Se-Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma
    Voss, Martin H.
    Molina, Ana M.
    Chen, Ying-Bei
    Woo, Kaitlin M.
    Chaim, Joshua L.
    Coskey, Devyn T.
    Redzematovic, Almedina
    Wang, Patricia
    Lee, William
    Selcuklu, S. Duygu
    Lee, Chung-Han
    Berger, Michael F.
    Tickoo, Satish K.
    Reuter, Victor E.
    Patil, Sujata
    Hsieh, James J.
    Motzer, Robert J.
    Feldman, Darren R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3846 - +
  • [27] Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial.
    Lee, Chung-Han
    Voss, Martin H.
    Carlo, Maria Isabel
    Chen, Ying-Bei
    Reznik, Eduard
    Knezevic, Andrea
    Lefkowitz, Robert A.
    Shapnik, Natalie
    Tassone, Diana
    Dadoun, Chloe
    Shah, Neil J.
    Owens, Colette Ngozi
    McHugh, Deaglan Joseph
    Aggen, David Henry
    Laccetti, Andrew Leonard
    Kotecha, Ritesh
    Feldman, Darren R.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] Sunitinib for Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Multicenter Retrospective Turkish Oncology Group Trial
    Yildiz, Ibrahim
    Ekenel, Meltem
    Akman, Tulay
    Kocar, Muharrem
    Uysal, Mukremin
    Kanitez, Metin
    Varol, Umut
    Bayoglu, Ibrahim Vedat
    Tural, Deniz
    Kaplan, Mehmet Ali
    Avci, Nilufer
    Surmeli, Zeki
    Dede, Isa
    Ulas, Arife
    Yazici, Ozan
    Basaran, Mert
    ANTICANCER RESEARCH, 2014, 34 (08) : 4329 - 4334
  • [29] Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial.
    Lee, Chung-Han
    Fitzgerald, Kelly N.
    Voss, Martin H.
    Carlo, Maria Isabel
    Knezevic, Andrea
    Peralta, Laura
    Chen, Ying-Bei
    Zucker, Mark
    Lefkowitz, Robert A.
    Reznik, Eduard
    Shah, Neil J.
    Owens, Colette Ngozi
    McHugh, Deaglan Joseph
    Aggen, David H.
    Laccetti, Andrew Leonard
    Kotecha, Ritesh R.
    Feldman, Darren R.
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Efficacy of sunitinib and sorafenib in non-clear cell renal cell carcinoma: Results from expanded access studies - In reply
    Choueiri, Toni K.
    Bukowski, Ronald M.
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) : 3471 - 3471
12345